Physician profile
Keyan Marashi
NPI 1437440492
$3,822.61
in general payments reported to CMS, 2019-2025
9 companies · $1,821 in 2025
The $1,821 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $807 · 2020: $12.10 · 2022: $235 · 2023: $569 · 2024: $378 · 2025: $1,821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,767.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Okami Medical, INC. | $1,640.39 | 2025 | Lobo |
| Sirtex Medical INC | $1,063.56 | 2019-2025 | Sir-Spheres Microspheres, Lava Les (Liquid Embolic System) |
| Cook Medical LLC | $268.22 | 2019-2025 | Zilver Ptx, Cook Celect |
| Biocompatibles, INC. | $253.86 | 2019 | |
| Trisalus Life Sciences, INC. | $247.92 | 2024 | Trinav Infusion System |
| Argon Medical Devices, INC. | $176.74 | 2019 | |
| Terumo Medical Corporation | $96.27 | 2019 | |
| Stryker Corporation | $59.31 | 2022 | |
| Teleflex LLC | $16.34 | 2023 | Arrow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keyan Marashi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.